170 related articles for article (PubMed ID: 8435796)
1. Thymic carcinoma. A distinct clinical entity responsive to chemotherapy.
Weide LG; Ulbright TM; Loehrer PJ; Williams SD
Cancer; 1993 Feb; 71(4):1219-23. PubMed ID: 8435796
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma.
Wang Y; Nie J; Dai L; Hu W; Chen X; Han J; Ma X; Tian G; Han S; Long J; Zhang Z; Fang J
Thorac Cancer; 2019 Jan; 10(1):17-23. PubMed ID: 30411854
[TBL] [Abstract][Full Text] [Related]
3. Systemic treatments for thymoma and thymic carcinoma: A systematic review.
Berghmans T; Durieux V; Holbrechts S; Jungels C; Lafitte JJ; Meert AP; Moretti L; Ocak S; Roelandts M; Girard N
Lung Cancer; 2018 Dec; 126():25-31. PubMed ID: 30527189
[TBL] [Abstract][Full Text] [Related]
4. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.
Lucchi M; Ambrogi MC; Duranti L; Basolo F; Fontanini G; Angeletti CA; Mussi A
Ann Thorac Surg; 2005 Jun; 79(6):1840-4. PubMed ID: 15919267
[TBL] [Abstract][Full Text] [Related]
5. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
[TBL] [Abstract][Full Text] [Related]
6. [The usefulness of induction chemotherapy in cases with tumors showing border-line pathological aspects between thymoma and thymic carcinoma].
Nonami Y; Moriki T; Yamamoto A; Yamashiro T; Sasaguri S; Nakata H; Kobayashi M
Kyobu Geka; 2002 Oct; 55(11):953-8. PubMed ID: 12391692
[TBL] [Abstract][Full Text] [Related]
7. Thymic carcinoma in children.
Yaris N; Nas Y; Cobanoglu U; Yavuz MN
Pediatr Blood Cancer; 2006 Aug; 47(2):224-7. PubMed ID: 16007580
[TBL] [Abstract][Full Text] [Related]
8. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
9. Role of chemotherapy in malignant thymoma.
Valente M; Schinzari G; Ricciotti A; Barone C
Ann Ital Chir; 2007; 78(5):377-80. PubMed ID: 18338542
[TBL] [Abstract][Full Text] [Related]
10. A case of successful preoperative chemotherapy with cisplatin and irinotecan followed by curative-intent surgery for locally advanced thymic carcinoma.
Suzuki S; Horio H; Hato T; Harada M; Okuma Y; Hishima T
Gen Thorac Cardiovasc Surg; 2013 Mar; 61(3):166-9. PubMed ID: 22760255
[TBL] [Abstract][Full Text] [Related]
11. Thymoma: Diagnosis and treatment.
Singh G; Rumende CM; Amin Z
Acta Med Indones; 2011 Jan; 43(1):74-8. PubMed ID: 21339550
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of docetaxel as a second-line chemotherapy for thymic carcinoma.
Oguri T; Achiwa H; Kato D; Maeda H; Niimi T; Sato S; Ueda R
Chemotherapy; 2004 Dec; 50(6):279-82. PubMed ID: 15608443
[TBL] [Abstract][Full Text] [Related]
13. Atypical thymoma: a report of seven patients.
Baran JL; Magro CM; King MA; Williams TE; Ross P
Ann Thorac Surg; 2004 Aug; 78(2):411-6. PubMed ID: 15276487
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of thymic carcinoma: analysis of seven cases and review of the literature.
Kitami A; Suzuki T; Kamio Y; Suzuki S
Jpn J Clin Oncol; 2001 Dec; 31(12):601-4. PubMed ID: 11902491
[TBL] [Abstract][Full Text] [Related]
15. Thymomas and thymic carcinomas.
Walker AN; Mills SE; Fechner RE
Semin Diagn Pathol; 1990 Nov; 7(4):250-65. PubMed ID: 2284513
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy.
Carlson RW; Dorfman RF; Sikic BI
Cancer; 1990 Nov; 66(10):2092-4. PubMed ID: 1699650
[TBL] [Abstract][Full Text] [Related]
17. Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.
Zucali PA; De Pas T; Palmieri G; Favaretto A; Chella A; Tiseo M; Caruso M; Simonelli M; Perrino M; De Vincenzo F; Toffalorio F; Damiano V; Pasello G; Garbella E; Ali M; Conforti F; Ottaviano M; Cioffi A; De Placido S; Giordano L; Bertossi M; Destro A; Di Tommaso L; Santoro A
J Clin Oncol; 2018 Feb; 36(4):342-349. PubMed ID: 29240542
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Docetaxel plus Cisplatin Chemotherapy for Myasthenia Gravis Patients with Metastatic Thymoma.
Qi G; Liu P; Dong H; Gu S; Yang H; Xue Y
Tohoku J Exp Med; 2017 Apr; 241(4):281-286. PubMed ID: 28381664
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with a five-drug regimen for invasive thymoma.
Bjerrum OW; Kiss K; Daugaard G
Acta Oncol; 1996; 35(1):71-3. PubMed ID: 8619943
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: evaluation of efficacy and toxicity.
Okuma Y; Hosomi Y; Takagi Y; Iguchi M; Okamura T; Shibuya M
Lung Cancer; 2011 Dec; 74(3):492-6. PubMed ID: 21665316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
